Impact of circulating cholesterol levels on growth and intratumoral androgen concentration of prostate tumors.
Prostate cancer (PCa) is the second most common cancer in men. Androgen deprivation therapy (ADT) leads to tumor involution and reduction of tumor burden. However, tumors eventually reemerge that have overcome the absence of gonadal androgens, termed castration resistant PCa (CRPC). Theories underly...
Main Authors: | Elahe A Mostaghel, Keith R Solomon, Kristine Pelton, Michael R Freeman, R Bruce Montgomery |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3261168?pdf=render |
Similar Items
-
Glucocorticoids and prostate cancer treatment: friend or foe?
by: Bruce Montgomery, et al.
Published: (2014-06-01) -
Prostate cancer characteristics associated with response to pre-receptor targeting of the androgen axis.
by: Elahe A Mostaghel, et al.
Published: (2014-01-01) -
Morphological heterogeneity of intratumoral macrophages in prostate tumors
by: K. V. Danilko, et al.
Published: (2023-01-01) -
Targeting intratumoral androgens: statins and beyond
by: Michael T. Schweizer, et al.
Published: (2016-09-01) -
Influence of obesity and androgen deficiency on prostatic blood circulation
by: I. A. Tyuzikov, et al.
Published: (2012-04-01)